Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2012 1
2016 1
2017 3
2018 1
2019 3
2020 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, Winder T, Zukov R, Garbaos G, Gao S, Kuroda H, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Papai-Szekely Z, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Doherty GJ, Mann H, Fouad TM, Reck M; AEGEAN Investigators. Heymach JV, et al. N Engl J Med. 2023 Nov 2;389(18):1672-1684. doi: 10.1056/NEJMoa2304875. Epub 2023 Oct 23. N Engl J Med. 2023. PMID: 37870974 Clinical Trial.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
Carbone DP, Reck M, Paz-Ares L, Creelan B, Horn L, Steins M, Felip E, van den Heuvel MM, Ciuleanu TE, Badin F, Ready N, Hiltermann TJN, Nair S, Juergens R, Peters S, Minenza E, Wrangle JM, Rodriguez-Abreu D, Borghaei H, Blumenschein GR Jr, Villaruz LC, Havel L, Krejci J, Corral Jaime J, Chang H, Geese WJ, Bhagavatheeswaran P, Chen AC, Socinski MA; CheckMate 026 Investigators. Carbone DP, et al. N Engl J Med. 2017 Jun 22;376(25):2415-2426. doi: 10.1056/NEJMoa1613493. N Engl J Med. 2017. PMID: 28636851 Free PMC article.
Association of virulence factors, phylogenetic groups and antimicrobial resistance markers in Escherichia coli from Badin city, Pakistan.
Kumar N, Nahid F, Zahra R. Kumar N, et al. J Chemother. 2017 Feb;29(1):8-13. doi: 10.1080/1120009X.2016.1154682. Epub 2016 Apr 11. J Chemother. 2017. PMID: 27077934
BACKGROUND: Escherichia coli, the most frequent cause of UTIs has extensive genetic substructure and can be assigned to eight phylogroups, A, B1, B2, C, D, E, F and Escherichia cryptic clade I. We investigated the distribution of virulence determinants and antimicrobial re …
BACKGROUND: Escherichia coli, the most frequent cause of UTIs has extensive genetic substructure and can be assigned to eight phylogroups, A …
Assessment of simplified methods for quantification of [(18)F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate.
Van Camp N, Balbastre Y, Herard AS, Lavisse S, Tauber C, Wimberley C, Guillermier M, Berniard A, Gipchtein P, Jan C, Badin RA, Delzescaux T, Hantraye P, Bonvento G. Van Camp N, et al. J Cereb Blood Flow Metab. 2020 May;40(5):1103-1116. doi: 10.1177/0271678X19859034. Epub 2019 Jun 25. J Cereb Blood Flow Metab. 2020. PMID: 31238764 Free PMC article.
We then performed a voxel-wise comparison of the different TSPO-PET quantification approaches providing parametric [(18)F]-DPA-714 PET images, with co-registered in vitro three-dimensional TSPO immunohistochemistry (3D-IHC) data. ...
We then performed a voxel-wise comparison of the different TSPO-PET quantification approaches providing parametric [(18)F]-DPA-714 PE …
Assessing the solar PV power project site selection in Pakistan: based on AHP-fuzzy VIKOR approach.
Solangi YA, Shah SAA, Zameer H, Ikram M, Saracoglu BO. Solangi YA, et al. Environ Sci Pollut Res Int. 2019 Oct;26(29):30286-30302. doi: 10.1007/s11356-019-06172-0. Epub 2019 Aug 20. Environ Sci Pollut Res Int. 2019. PMID: 31432370
Later, fuzzy VlseKriterijuska Optimizacija I Komoromisno Resenje (F-VIKOR) method has been employed to prioritize the 14 alternatives. The present investigation reveals that Khuzdar (C2), Badin (C3), and Mastung (C7) are the most suitable cities for the installation …
Later, fuzzy VlseKriterijuska Optimizacija I Komoromisno Resenje (F-VIKOR) method has been employed to prioritize the 14 alternatives …
Rehabilitation of speech disorders following glossectomy, based on ultrasound visual illustration and feedback.
Girod-Roux M, Hueber T, Fabre D, Gerber S, Canault M, Bedoin N, Acher A, Béziaud N, Truy E, Badin P. Girod-Roux M, et al. Clin Linguist Phon. 2020 Sep 1;34(9):826-843. doi: 10.1080/02699206.2019.1700310. Epub 2020 Jan 28. Clin Linguist Phon. 2020. PMID: 31992079
The IF cohort benefitted from 10 sessions using illustration alone (IL condition) followed by 10 sessions using illustration supplemented by visual feedback (IL+F condition). The FI cohort followed the opposite protocol, i.e. the first 10 sessions with the IL+F cond …
The IF cohort benefitted from 10 sessions using illustration alone (IL condition) followed by 10 sessions using illustration supplemented by …
Gene Therapy for Parkinson's Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis.
Badin RA, Binley K, Van Camp N, Jan C, Gourlay J, Robert C, Gipchtein P, Fayard A, Stewart H, Ralph GS, Lad Y, Kelleher M, Loader J, Hosomi K, Palfi S, Mitrophanous KA, Hantraye P. Badin RA, et al. Mol Ther Methods Clin Dev. 2019 Jul 16;14:206-216. doi: 10.1016/j.omtm.2019.07.002. eCollection 2019 Sep 13. Mol Ther Methods Clin Dev. 2019. PMID: 31406701 Free PMC article.
At 6 months post-vector administration, all treated animals showed significant improvements in clinical scores and spontaneous locomotor activity compared to controls, with the highest recovery observed in the OXB-102 high-dose (HD) group. Positron emission tomography quantificat …
At 6 months post-vector administration, all treated animals showed significant improvements in clinical scores and spontaneous locomotor act …
12 results